News Similar Efficacy for Key Anti-VEGF Agents in Macular Edema by Medscape • 2017/06/20 • 0 Comments The SCORE2 trial shows that bevacizumab and aflibercept may produce similar short-term outcomes. Here is a closer look at its results. Medscape Optometry Full Story →